Post-Acute Care Outcomes, Adherence Research, Vulnerable Populations Research, Affordablity/Access to High-Quality Care
Associate Professor of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
Dr. Watanabe seeks to determine factors that jeopardize appropriate medication use. Dr. Watanabe practices in Senior Care Pharmacy and focuses on outcomes in older adults and residents of extended care facilities. He has completed investigations on 1) the role of adherence on surrogate markers for chronic conditions; 2) the effect of copayment and copayment pricing on adherence; 3) the impact of polypharmacy on adherence; 4) the role of pharmacy benefit on health services; 5) methods used in health services research applying large national data.
Collaborating with an interdisciplinary care team, Professor Watanabe initiated longitudinal assessments of outcomes in Post-Acute Care Settings and characterized those at risk for poor adherence and compromised health outcomes in Veterans with chronic diseases. He has served as an invited speaker at several international forums devoted to improving care for seniors in long term care settings and provided presentations on pharmacy benefit and evaluation at the National Academy of Sciences. He currently trains students, post-docs, and practitioners in multiple disciplines in clinical research and post-acute care.
Professor Watanabe is a clinical consultant for the Program of All-inclusive Care for the Elderly (PACE) Clinic in San Diego, CA and the Villa Pomerado Skilled Nursing Facility in Poway, CA . He is an investigator on the Health Resources and Services Administration funded San Diego Geriatrics Workforce Enhancement Program Grant. Dr. Watanabe was the inaugural recipient of the University of Washington/Allergan Health Economics and Outcomes Research Fellowship. Watanabe serves as the advisor for the Academy of Managed Care Pharmacy student chapter. Dr. Watanabe serves the CA State Legislature as a faculty content expert for the California Health Benefits Review Program. He serves as a member of the advisory group on pain assessment and management standards for long-term care organizations for The Joint Commission. He was a contributing author to the Making Medicines Affordable consensus report from the National Academies of Sciences, Engineering, and Medicine. He is a Board Certified Geriatric Pharmacist (BCGP).
B.S. in Zoology (University of Washington); Pharm.D. (University of Southern California); M.S. (University of Washington); Ph.D. (University of Washington).
Awards and Honors:
University of Washington Distinguished Alumna in Pharmaceutical Science and Research (2018). National Academy of Medicine (NAM) Emerging Leader in Health and Medicine (2018-2021). NAM Pharmacy Fellow (2016-2018). National Institutes of Health Loan Repayment Program Investigator (National Institute on Aging).
- Administration Pharmacy (SSPS 298)
- Introduction to Healthcare Systems and Policy (SPPS 207)
- Enhanced understanding of adherence on clinically validated outcome measures in chronic diseases.
- Proposed alternative adherence threshold based on robust outcomes assessment.
- Quantified role in appropriate medication use and emergency department visits.
- Applied outcomes research framework to Long Term Care Pharmacy practice.
- Watanabe JH et al. (2014) Association of copayment with likelihood and level of adherence in new users of statins. J Mang Care Pharm 20:43-50.
- Watanabe JH et al. (2015) Generic medication utilization policies in the United States and Medicaid sustainability. JFPSR 6 (1):3-10.
- Alfonso-Cristancho et al. (2015) Definition and classification of generic drugs across the world. Appl Health Econ Health Policy. 13 Suppl 1:S5-11.
- Watanabe JH et al. (2018) Association of polypharmacy and statin new-user adherence in a veterans health administration population: a retrospective cohort study. Ann Pharmacother 47(10):1253-9.
- Watanabe JH et al. (2018) Federal and individual spending on the 10 costliest medications in Medicare Part D from 2011 to 2015. J Am Geriatr Soc. 2018 Aug;66(8):1621-1624.
- Watanabe JH et al. (2018) Cost of prescription drug-related morbidity and mortality. Ann Pharmacother. 2018 Sep;52(9):829-837.